• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • NTDs

    What not to neglect in tackling NTDs

    How can the global health community mobilize the $750 million needed annually to eradicate neglected tropical diseases by 2020? Devex asked two health experts from the World Health Organization and the Bill & Melinda Gates Foundation.

    By Jenny Lei Ravelo // 19 February 2015

    The global health community needs an estimated $750 million annually to meet the World Health Organization’s 2020 road map for the preventive treatment and care of neglected tropical diseases.

    It is relatively cheap, when compared with the billions of dollars needed to address other health issues like HIV and AIDS, to which U.S. President Barack Obama allocated $6.2 billion under his 2015 budget request.

    Yet meeting that target has been a struggle, according to Dirk Engels, head of WHO’s NTD department. In fact, he said, there’s currently just about $300 million in foreign aid funding available to tackle these diseases — not even half of the required sum.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in
    • Funding
    • Global Health
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Jenny Lei Ravelo

      Jenny Lei Ravelo@JennyLeiRavelo

      Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.

    Search for articles

    Related Stories

    Sponsored by the END FundCan partnerships and pooled funding drive NTD elimination?

    Can partnerships and pooled funding drive NTD elimination?

    Escape the Neglect: Produced in PartnershipWhy drug donation programs are a lifeline for NTD elimination efforts

    Why drug donation programs are a lifeline for NTD elimination efforts

    Escape the Neglect: Produced in PartnershipBridging NTD innovation and access gaps in global health

    Bridging NTD innovation and access gaps in global health

    Global healthUganda receives first pediatric drug for schistosomiasis. What's next?

    Uganda receives first pediatric drug for schistosomiasis. What's next?

    Most Read

    • 1
      Opinion: How climate philanthropy can solve its innovation challenge
    • 2
      Closing the loop: Transforming waste into valuable resources
    • 3
      The legal case threatening to upend philanthropy's DEI efforts
    • 4
      How is China's foreign aid changing?
    • 5
      FfD4 special edition: The key takeaways from four days in Sevilla
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement